Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours

BackgroundHemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings.AimsTo assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer.MethodsThe endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study.ResultsImmediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30 days and 50% at six months.ConclusionHemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings.